IP Library › Patent Application 63328951
Patent Application Provisional Small
App. No. 63/328,951 · Confirmation No. 1706

DR5 Agonist and PLK1 Inhibitor Combination Therapy

Applicant: Inhibrx, Inc.
Provisional Application Expired
⬇ PDF
 Code Description Pages PDF
2022-04-26 APP.FILE.REC Filing Receipt 3 View
2022-04-08 SCORE Placeholder sheet indicating presence of supplemental content in Supplemental Complex Repository for Examiners(SCORE) 1 View
2022-04-08 ADS Application Data Sheet 8 View
2022-04-08 SPEC Specification 42 View
2022-04-08 CLM Claims 4 View
2022-04-08 ABST Abstract 1 View
2022-04-08 DRW.NONBW Drawings-other than black and white line drawings 12 View
2022-04-08 WFEE Fee Worksheet (SB06) 2 View
2022-04-08 N417 Electronic Filing System Acknowledgment Receipt 3 View
2022-04-08 DRW.SUPP Drawings-black and white line and/or other drawings — View
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
App. No.
63/328,951
Filed
2022-04-08